title: Quo vadis: the re-definition of "inborn metabolic diseases".
authors.affiliation: Department of Pediatrics, Tulane University Medical School, New Orleans, LA, USA. emoravakozicz@tulane.edu.|Department of Pediatrics, University Medical School of Leuven, Leuven, Belgium. emoravakozicz@tulane.edu.
authors.forename: Eva
authors.initials: E
authors.lastname: Morava
authors.affiliation: Mitochondrial Research Group, Genetics and Genomic Medicine, UCL Institute of Child Health, and Metabolic Department, Great Ormond Street Hospital, London, UK.
authors.forename: Shamima
authors.initials: S
authors.lastname: Rahman
authors.affiliation: Centre for Paediatric and Adolescence Medicine, University of Heidelberg, Heidelberg, Germany.
authors.forename: Verena
authors.initials: V
authors.lastname: Peters
authors.affiliation: Division of Metabolism and Children's Research Center, University Children's Hospital, Zurich, Switzerland.
authors.forename: Matthias R
authors.initials: MR
authors.lastname: Baumgartner
authors.affiliation: Division of Child and Adolescent Neurology, Children's Center, Mayo Clinic, Rochester, MN, USA.
authors.forename: Marc
authors.initials: M
authors.lastname: Patterson
authors.affiliation: Division of Human Genetics, Medical University Innsbruck, Innsbruck, Austria.
authors.forename: Johannes
authors.initials: J
authors.lastname: Zschocke
mesh_terms: D018981:Congenital Disorders of Glycosylation / Q000235:genetics*; D006801:Humans; D008661:Metabolism, Inborn Errors / Q000235:genetics*; D028361:Mitochondrial Diseases / Q000235:genetics*